SLXNW
Silexion Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.01
+23.89%Institutional positioning
13F filings over the trailing two quarters
New 0Increased 1Reduced 2Sold out 21
| Filer | Action | Shares | Filed |
|---|---|---|---|
| POLAR ASSET MANAGEMENT PARTNERS INC. | Unchanged | 743,475 | May 15, 2026 |
| LINDEN ADVISORS LP | Unchanged | 337,500 | May 15, 2026 |
| ARISTEIA CAPITAL LLC | Unchanged | 236,546 | May 15, 2026 |
| CLEAR STREET GROUP INC. | Reduced | 218,765 | May 15, 2026 |
| SECURITY BENEFIT LIFE INSURANCE CO /KS/ | Unchanged | 150,000 | May 4, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 123,494 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 121,237 | Mar 25, 2026 |
| KEPOS CAPITAL LP | Unchanged | 100,000 | May 12, 2026 |
| JANE STREET GROUP, LLC | Unchanged | 74,910 | May 12, 2026 |
| PICTON MAHONEY ASSET MANAGEMENT | Unchanged | 57,175 | May 13, 2026 |
| CONTEXT CAPITAL MANAGEMENT, LLC | Unchanged | 51,183 | May 7, 2026 |
| TENOR CAPITAL MANAGEMENT CO., L.P. | Unchanged | 50,000 | May 15, 2026 |
| GABELLI & CO INVESTMENT ADVISERS, INC. | Unchanged | 38,150 | May 14, 2026 |
| DUPONT CAPITAL MANAGEMENT CORP | Unchanged | 32,500 | Apr 23, 2026 |
| NEUBERGER BERMAN GROUP LLC | Unchanged | 31,552 | May 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings